ONYX Pharmaceuticals : Proteolix Dealogic Deal # : 649523
Data as of : 10/12/2009
Target Acquiror Dates & Values
Proteolix ONYX Pharmaceuticals
Target: 100 % stake Buying: 100 % stake Rumored - Deal Value $m 851.0
Unlisted 0 0 m shares outstanding Public (Listed) Announced 12th Oct 2009 Value ex Debt $m 851.0
United States United States
Healthcare Healthcare Expected 4Q 2009 Consideration
Cooley Godward | Attorney Completed -
Withdrawn -
Termination Fee, Target $m tbd
Termination Fee, Acquiror $m tbd
Financials -
Balance Sheet Debt/Equity: -
Timeline Events Premiums & Multiples
Initial Offer $0.00
Current Offer -
Income Statement
Cash Flows
Operations $m 0
Profitability
Profit Margin -
Return on Equity -
League Table Impact Sector Trend
2009 YTD Announced Global M&A by Deal Value, $bn Monthly Announced Global M&A, $bn: Healthcare
1 Goldman Sachs 480.9
2 Morgan Stanley 473.8
3 JPMorgan 462.1
4 Citi 378.2
5 Lazard 279.3
6 BOA Merrill Lynch 275.3
7 Deutsche Bank 251.5
8 Credit Suisse 249.8
9 UBS 244.0
10 Barclays Capital 163.4
2009 Dealogic. All rights reserved.